Social & Media

Home / Social & Media / Webcasts/Videos / ‘Check up’ reports on rare disease EPP and SCENESSE® (afamelanotide)

‘Check up’ reports on rare disease EPP and SCENESSE® (afamelanotide)

On 31 January 2012 Swiss TV channel Telezueri aired a report on erythropoietic protoporphyria (EPP), a rare genetic disorder which causes absolute intolerance of skin to sunlight, and CLINUVEL’s novel drug SCENESSE® (afamelanotide), which has been trialed as a photoprotective in EPP. CLINUVEL has subtitled the ‘Check up’ program and re-released for the broader EPP community. All footage and soundtrack are copyright© Telezueri 2012.